Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay K Chhablani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Indian Journal of Ophthalmology|August 13, 2011
Delayed inflammation associated with retained perfluorocarbon liquidS Pradeep, Jay K Chhablani, Bhavin Patel, et al.
Indian Journal of Ophthalmology|August 22, 2018
Response to: Transzonular drug delivery during cataract surgery: Is dropless cataract surgery really beneficial?Prafulla K Maharana, Jay K Chhablani, Taraprasad Das, et al.
Indian Journal of Ophthalmology|May 23, 2018
All India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017Prafulla Kumar Maharana, Jay K Chhablani, Tara Prasad Das, et al.
American Journal of Ophthalmology|August 2, 2024
Geographical Trends in Global Ophthalmology Research From 2002 to 2022Selina J Chang, Amrish Selvam, Sydney DeVore, et al.
Indian Journal of Ophthalmology|February 20, 2019
Pachydrusen in Indian population: A hospital-based studySumit Randhir Singh, Avadhesh Oli, Sashwanthi Mohan, et al.
Retina (Philadelphia, Pa.)|February 4, 2016
CorrespondenceMichael W Stewart, Maurice B Landers, David J Browning, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 8, 2026
Progression of hydroxychloroquine-induced retinopathy after drug cessationRichard B Brown, Alice M Kitay, Matthew Driban, et al.
Seminars in Ophthalmology|March 28, 2025
Protocol for a Randomized Controlled Trial Comparing Intravitreal Brolucizumab with Placebo for Chronic Central Serous Chorioretinopathy with Persistent Macular Fluid Without Choroidal Neovascular Membrane - BRICS Report #1Srishti Raksheeth Ramamurthy, Saarang Hansraj, Ritesh Narula, et al.
American Journal of Ophthalmology|December 13, 2025
A Randomized-Controlled Trial of the Efficacy, Safety and Tolerability of Intravitreal Brolucizumab in Patients With Chronic Central Serous Chorioretinopathy With Persistent Fluid in the Absence of Choroidal Neovascular Membrane-BRICS Trial Report IISrishti Raksheeth Ramamurthy, Saarang Hansraj, Ragu Kumar, et al.
BMC Nephrology|February 2, 2020
Association of reduced inner retinal thicknesses with chronic kidney diseaseEuan N Paterson, Meera L Ravindran, Kayleigh Griffiths, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Indian Journal of Ophthalmology|August 13, 2011
Delayed inflammation associated with retained perfluorocarbon liquidS Pradeep, Jay K Chhablani, Bhavin Patel, et al.
Indian Journal of Ophthalmology|August 22, 2018
Response to: Transzonular drug delivery during cataract surgery: Is dropless cataract surgery really beneficial?Prafulla K Maharana, Jay K Chhablani, Taraprasad Das, et al.
Indian Journal of Ophthalmology|May 23, 2018
All India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017Prafulla Kumar Maharana, Jay K Chhablani, Tara Prasad Das, et al.
American Journal of Ophthalmology|August 2, 2024
Geographical Trends in Global Ophthalmology Research From 2002 to 2022Selina J Chang, Amrish Selvam, Sydney DeVore, et al.
Indian Journal of Ophthalmology|February 20, 2019
Pachydrusen in Indian population: A hospital-based studySumit Randhir Singh, Avadhesh Oli, Sashwanthi Mohan, et al.
Retina (Philadelphia, Pa.)|February 4, 2016
CorrespondenceMichael W Stewart, Maurice B Landers, David J Browning, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 8, 2026
Progression of hydroxychloroquine-induced retinopathy after drug cessationRichard B Brown, Alice M Kitay, Matthew Driban, et al.
Seminars in Ophthalmology|March 28, 2025
Protocol for a Randomized Controlled Trial Comparing Intravitreal Brolucizumab with Placebo for Chronic Central Serous Chorioretinopathy with Persistent Macular Fluid Without Choroidal Neovascular Membrane - BRICS Report #1Srishti Raksheeth Ramamurthy, Saarang Hansraj, Ritesh Narula, et al.
American Journal of Ophthalmology|December 13, 2025
A Randomized-Controlled Trial of the Efficacy, Safety and Tolerability of Intravitreal Brolucizumab in Patients With Chronic Central Serous Chorioretinopathy With Persistent Fluid in the Absence of Choroidal Neovascular Membrane-BRICS Trial Report IISrishti Raksheeth Ramamurthy, Saarang Hansraj, Ragu Kumar, et al.
BMC Nephrology|February 2, 2020
Association of reduced inner retinal thicknesses with chronic kidney diseaseEuan N Paterson, Meera L Ravindran, Kayleigh Griffiths, et al.
Pageof 2